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Abstract
Using lines of mice having undergone long-term se-
lection for high and low growth, a large-sample (n =
1,000 F2) experiment was conducted to gain further
understanding of the genetic architecture of complex
polygenic traits. Composite interval mapping on
data from male F2 mice (n = 552) detected 50 QTL on
15 chromosomes impacting weights of various organ
and adipose subcomponents of growth, including
heart, liver, kidney, spleen, testis, and subcutaneous
and epididymal fat depots. Nearly all aggregate
growth QTL could be interpreted in terms of the
organ and fat subcomponents measured. More than
25% of QTL detected map to MMU2, accentuating
the relevance of this chromosome to growth and
fatness in the context of this cross. Regions of
MMU7, 15, and 17 also emerged as important obes-
ity ‘‘hot-spots.’’ Average degrees of directional
dominance are close to additivity, matching expec-
tations for body composition traits. A strong QTL
congruency is evident among heart, liver, kidney,
and spleen weights. Liver and testis are organs
whose genetic architectures are, respectively, most
and least aligned with that for aggregate body
weight. In this study, growth and body weight are
interpreted in terms of organ subcomponents un-
derlying the macro aggregate traits, and anchored on
the corresponding genomic locations.
An estimated 65% of U.S. adults are overweight, and
31% are obese (Flegal et al. 2002). Overweight and
obesity substantially increase the risk of hyperten-
sion, dyslipidemia, type 2 diabetes, coronary heart
disease, stroke, gallbladder disease, osteoarthritis,
sleep apnea and respiratory problems, and endome-
trial, breast, prostate, and colon cancers, combining
to form the single largest cause of death in developed
countries (NHLBI, 1998). While molecular biology
has yielded significant advancements in understand-
ing weight regulation at the metabolic and physio-
logical levels, an alarmingly low number of cases of
obesity in humans can be attributed to mutations
within genes exerting effects in well-characterized,
energy-balance pathways (Chagnon et al. 2003).
Carcass and body composition traits also con-
stitute extremely important considerations of mod-
ern livestock production systems where consumer
health concerns and marketing perspectives play
increasingly prominent roles (Lasater and Kingsbery
1987; Smith 1991). The problem of excess fat in
livestock and poultry carcasses is ubiquitous and has
serious consequences for the animal industry at four
levels: health perceptions of consumers; wasteful
production of an undesired biological component;
labor costs of trimming waste fat; and lower biolog-
ical efficiencies of fatter animals (Eisen 1989).
Understanding the complex genetic architecture
underlying quantitative trait variation for growth
and body weight in mice has recently been advanced
by use of crosses of large sample sizes, with an em-
phasis on localizing and defining the nature of QTL
for these traits (e.g., Vaughn et al. 1999; Rocha et al.
2004a). While many QTL studies have focused on
body fat as a biomedically and agriculturally relevant
trait (e.g., reviewed by Pomp 1997; Brockmann and
Bevova 2002), fewer investigations have evaluated
components of body weight with a more global ap-
proach encompassing body fatness as well as organ
weights and estimates of lean mass.
We created and evaluated a large sample from an
F2 cross between lines of mice that had undergone
long-term selection for rapid growth rate and low
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body weight to identify QTL for a variety of complex
traits, including body weight and growth (Rocha et al.
2004a). In the present study we report on compo-
nents of growth including weights of many organs
and indicators of body fatness and leanness in males
of the F2.
Materials and methods
Relevant information pertaining to the parental high
growth (M16i) and low body weight (L6) selection
lines, development of the F2 intercross population,
and marker genotyping have been presented in a
companion paper (Rocha et al. 2004a). Only methods
relevant to the specific organ and body composition
trait phenotypes evaluated and their statistical data
analysis will be described here.
Phenotypes. Ten-week-old males (n = 552) from
the F2 cross described in Rocha et al. (2004a) were
weighed (WT10wk) and euthanized by cervical dis-
location. Heart (HRT), liver (LIV), spleen (SPL), right
kidney (KID), right testis (TES), right hindlimb sub-
cutaneous fat pad (SCF), and right epididymal fat pad
(EPF) were immediately excised and wet weights
recorded. All organs were returned to the body cavity
except for the spleen, which was used for subsequent
DNA extraction. Gastrointestinal contents were
flushed with tap water, blotted, and wet body weight
(w) was recorded. The carcass was then lyophilized
to a constant weight (d), and percentage water
(PWAT), a proxy for leanness of the organism, was
calculated as 100 · (w  d)/w. Two additional traits
analyzed were FAT, the sum of SCF and EPF, and
SCF/EPF, their ratio. Least squares means for related
traits for the grandparental M16i and L6 lines were,
respectively, 57.9 vs. 18.4 g for WT10wk, 7.92 vs.
6.00% for LIV, 0.23 vs. 0.39% for TES, and 0.80 vs.
0.67% for EPF, with weights of organs expressed as
percentages of WT10wk.
Data analyses. Descriptive statistics and phen-
otypic correlations for organ and adipose traits are
presented in Tables 1 and 2. Appropriate statistical
models were identified for each trait by fitting gen-
eralized linear models (PROC GLM; SAS Institute
Inc. 1985, 1996), including fixed effects of replicate/
parity, full-sib family/litter, and respective interac-
tions, if significant. Residuals were analyzed with
QTL Cartographer (Version 1.15; Basten et al. 2001)
to perform composite interval mapping (CIM; Zeng
1993, 1994). With the exception of SCF/EPF, loga-
rithmic transformation was employed prior to com-
posite interval mapping to correct patterns of
heteroscedasticity. Day of tissue harvest was a sig-
nificant source of phenotypic variation and was in-
cluded in the statistical models as a nested term
within replicate. Interestingly, animals born in lit-
ters from the second parity of F1 dams tended to
exhibit heavier organs but were leaner, an effect that
was particularly noticeable for the subcutaneous fat
pad (data not shown).
QTL analyses were also performed with three
sets of covariate adjustments: 1) WT10wk; 2) FAT;
and 3) both WT10wk and FAT. The purpose of these
adjustments was to attempt to identify alternate sets
of QTL involved in different pathways responsible
for the fluctuating patterns of phenotypic and ge-
netic correlations observed among the various traits.
In the body weight-adjusted models, relationships of
organ and fat weights with WT10wk were always
linear and positive (as also evident from phenotypic
correlations). Estimates of regression coefficients for
WT10wk were negative for PWAT and SCF/EPF. The
former was expected, since heavier animals are fatter
and PWAT is a proxy for leanness. The latter result
may indicate that increased body weight leads to
higher rate of deposition of epididymal versus sub-
cutaneous fat. For the FAT-adjusted models, quad-
ratic terms were used in some cases owing to minor
deviations from linearity. The sign of the regression
coefficient for FAT changed from positive to nega-
tive when WT10wk was also used as a covariate,
indicating that at a constant body weight, fatter an-
imals tended to have smaller organ weights.
The threshold adopted in the forward-backward
stepwise regression factor-selection procedures for
CIM was 0.001 for statistical models not including
adjustment for WT10wk, and 0.01 when such ad-
justments were included. A 10-cM window size was
Table 1. Descriptive statistics for organ and fat traits in
this studya
Traits N l r Range
HRT mg 551 211.8 40.5 120–425
LIV mg 552 2274.6 389.2 1150–3665
KID mg 552 267.2 46.0 98–445
SPL mg 551 142.6 41.2 63–410
TES mg 552 105.6 19.0 46–212
SCFb mg 552 190.6 99.9 29–688
EPFb mg 552 404.9 184.3 101–1183
FATb mg 552 595.5 265.3 158–1870
SCF/EPFb% 552 0.49 0.17 0.10–1.28
PWATc% 541 63.5 3.4 42.0–72.5
aHRT, LIV, KID, SPL, TES, SCF, EPF, PWAT are weights of Heart,
Liver, Kidney, Spleen, Testis, Subcutaneous fat pad, Epididymal
fat pad, and percentage water in carcass. FAT = (SCF + EPF). All
traits measured in F2 males at 10 weaks of age.
bSubcutaneous and epididymal fat pad weights, their sum (FAT),
and ratio.
cProximal determination of water content of the organism.
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used. Permutations were performed for organ and fat
traits, and when similar results were observed for all
traits, their permutations were pooled, leading to
adoption of LOD = 3.3 for the 5% genomewise sig-
nificance threshold (Churchill and Doerge 1994; see
Rocha et al. 2003a).
Results
A summary of all identified QTL and related QTL
detected by other studies in the same genomic re-
gions are presented in Table 3. To avoid duplication,
results from models including adjustment for
WT10wk (designated as HRT%, KID%, etc.; Table 3)
are presented only when they identified QTL not
detected from the unadjusted models. Models in-
cluding adjustment for FAT identified QTL results
similar to those found when not including such ad-
justments, so they will not be considered further.
Results for the composite trait FAT (sum of SCF and
EPF) simply reproduced QTL that were detected for
the sub-components (subcutaneous and epididymal
fat pads), so they will not be reported. Furthermore,
no QTL were detected for SCF/EPF, or for WT10wk
once this trait was adjusted for all organ weights.
A total of 50 significant QTL were detected, and
each was assigned a locus symbol following MGD
guidelines (Table 3). QTL (n) were detected for HRT
(3), TES (3), LIV (10), KID (7), SPL (9), SCF (4), EPF (5),
and PWAT (1). Additional QTL (n) were detected
when traits were adjusted for WT10wk, including
HRT% (1), KID% (2), SCF% (1),and EPF% (4). For
unadjusted traits, the vast majority of QTL exhibited
additive gene action with the M16i allele1 increasing
organ and fat pad weights. For traits adjusted for
WT10wk, M16i alleles had both positive and nega-
tive additive effects depending upon the locus (see
Table 3).
Tables 4 and 5 summarize QTL information
across traits, while Table 2 presents the QTL-con-
gruencies [QTL common to two traits (overlapping
confidence intervals) as a proportion of the total
number of QTL detected for the two traits] in rela-
tion to the respective phenotypic correlations. Large
QTL-congruencies among heart, liver, kidney, and
spleen weights are particularly evident, in agreement
with phenotypic correlations. Liver weight appears
to be controlled by a genetic architecture that is
most aligned with body weight, while the reverse is
true for testis weight, where no QTL congruencies
were found with any other trait.
QTL for most organ and all fat pad weights dis-
play a prevalence for additive gene action. Testis and
spleen weights, as might be expected given their
Table 2. Phenotypic correlations (top row) and QTL congruenciesa (bottom row) among the organ and fat traitsb
Traits HRT LIV KID SPL TES SCF EPF FATc SCF/EPFd PWAT WT10wk
HRT 1.0 0.49 0.53 0.31 0.11 007ns 0.22 0.18 0.21 0.05ns 0.49
0.40 0.44 0.30 0.0 0.29 0.18 – 0.0 0.0 0.22
LIV – 1.0 0.66 0.57 0.21 0.27 0.40 0.38 0.13 0.14 0.81
0.58 0.36 0.0 0.25 0.27 – 0.0 0.10 0.40
KID – – 1.0 0.34 0.22 0.13 0.27 0.24 0.19 0.00ns 0.63
0.39 0.0 0.17 0.29 – 0.0 0.11 0.35
SPL – – – 1.0 0.07ns 0.14 0.24 0.22 0.12 0.02ns 0.53
0.0 0.17 0.29 – 0.0 0.11 0.35
TES – – – – 1.0 0.11 0.13 0.13 0.02ns 0.04ns 0.25
0.0 0.0 – 0.0 0.0 0.05
SCF – – – – – 1.0 0.72 0.88 0.45 0.67 0.47
0.40 – 0.0 0.0 0.21
EPF – – – – – – 1.0 0.97 0.22 0.78 0.64
– 0.0 0.0 0.23
FAT – – – – – – – 1.0 0.02ns 0.79 0.63
0.0 – –
SCF/EPF – – – – – – – – 1.0 0.00ns 0.16
0.0 0.0
PWAT – – – – – – – – – 1.0 0.36
0.06
aQTL common to both traits (overlapping confidence intervals) as a proportion of the total number of QTL detected for the two traits. Cf.
legends of Tables 1, 3, and 5.
bHRT, LIV, KID, SPL, TES, SCF, EPF, PWAT are symbols attributed to weights of Heart, Liver, Kidney, Spleen, Testis, Subcutaneous fat
pad, Epididymal fat pad, and percentage water in carcass. FAT = (SCF + EPF). All traits measured in F2 males 10 weeks of age. Correlations
for the most part were highly significant (p < 0.0001); nsindicates p > 0.05.
cRelative to QTL for SCF and EPF, no unique results for FAT were found, and it was not considered in the QTL congruency results.
dNo QTL for SCF/EPF were identified.
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Table 3. QTL detected and respective statistics by chromosome
MMU Symbola
Flanking
markersb
Positionc
cM ad de %Vf LOD Other studiesg
1 Lvrq3 180–72 59.5 0.28 0.48 5.1 7.3 B3
48.9–72.7
1 Splq3 72–200 67.4 0.24 0.10 3.9 5.6 L, Rb
55.2–78.1
1 Pwatq1 72–200 72.7 0.20 0.0 3.1 3.7 B3, L, Mc, Md,
PH, S, T4
51.6–86.6
1 Kidq2 72–200 75.4 0.31 0.12 5.9 10.2 B3, I, L
70.0–84.7
1 Splq5 200–223 93.2 0.28 0.36 6.3 5.4
80.9–103.5
2 Hrtq1 6–133 52.2 0.34 0.18 12.8 6.4 B2
38.0–70.3
2 Kidq1 6–133 52.2 0.43 0.57 17.2 10.3 B2
42.7–66.8
2 Splq1 6–133 57.9 0.34 0.08 11.2 6.8 B2, L
45.6–72.7
2 Lvrq1 6–133 59.7 0.54 0.18 23.3 18.9 B2-3, L
51.2–69.2
2 Epf%q2 133–224 66.8
52.2–72.7
0.3 0.48 1.0 3.8 B2-3, H, Lb,
M, P, T2-4
2 Kidq3 224–22 77.8 0.29 0.20 4.9 6.8 B2
74.0–81.6
2 Lvrq2 224–22 79.1 0.46 0.01 9.9 15.1 B3
76.5–81.7
2 Splq2 224–22 79.1 0.28 0.28 4.4 5.9
74.0–83.0
2 Hrtq2 224–22 80.4 0.27 0.36 5.0 5.7
75.9–84.0
2 Scfq1 22–49 84.0 0.26 0.35 5.9 7.6 B3, Lb, M, Sc
81.7–88.9
2 Epfq1 22–49 84.0 0.31 0.47 6.7 9.5 B3, Lb, M, Sc
79.8–87.6
2 Epfq2 49–148 97.6 0.25 0.01 4.3 4.6 B3, M-2, P, Sc
95.5–102.4
3 Splq6 130–97 22.1 0.28 0.47 7.0 4.8 Md
10.0–33.2
3 Lvrq5 130–97 24.1 0.28 0.31 9.7 5.3 B3, L, Md
14.0–44.7
3 Hrt%q1 130–97 30.2 0.23 0.9 4.3 3.5 L, Md
16.0–53.0
3 Kidq7 97–18 53.0 0.23 0.28 8.0 3.5 B2, L, Md
22.1–65.4
4 Lvrq9 1–27 32.6 0.25 0.11 10.3 3.9 B2-3, Md
15.3–42.5
4 Kidq4 1–27 42.5 0.21 0.06 6.4 5.3 B3, Md
19.5–52.1
4 Lvrq8 27–64 49.3 0.24 0.10 5.0 4.0 B2-3
42.5–58.2
6 Tesq2 132–201 44.9 0.13 2.1 7.3 4.4 Sp
27.9–56.3
7 Kidq5 55–91 15.0 0.21 0.38 1.9 5.3 B3
?–23.1
7 Splq7 55–91 16.6 0.22 0.13 3.2 4.5 B3
?–24.8
7 Lvrq6 55–91 21.5 0.23 0.31 3.0 5.0 B3, T3
?–28.1
7 Epfq5 55–91 21.5
?–35.9
0.19 0.41 2.6 3.4 B3, Mc, Md,
PH, T-3, W2
7 Kidq6 11–105 63.5 0.18 0.23 1.3 3.8
54.5–?
(Continued)
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Table 3. Continued
MMU Symbola
Flanking
markersb
Positionc
cM ad de %Vf LOD Other studiesg
9 Splq4 105–19 49.7 0.42 0.81 16.0 5.6 B3, L
35.0–58.4
10 Kid%q2 1–65 11.8 0.09 3.7 7.0 3.4
?–23.4
10 Hrtq3 1–65 27.3 0.26 0.12 6.2 4.2 L
13.7–44.6
10 Scf%q1 1–65 33.1 0.19 2.3 12.0 3.9 B3
20.5–55.3
10 Lvrq4 1–65 37.0 0.23 1.3 7.4 5.5 B3
26.3–53.2
10 Tesq3 65–35 69.0 0.19 0.36 3.3 3.9 LeR
58.2–?
11 Epfq4 2–4 17.4 0.22 0.43 2.5 3.5 B-2-3, Mc, Md
?–34.9
11 Kid%q1 2–4 19.9 0.25 1.2 6.1 4.5 B-2-3, I, L, Md
6.2–39.1
11 Lvrq7 2–4 24.9 0.24 0.05 2.7 4.6 B-2-3, L, Md
11.1–45.4
11 Scfq3 2–4 24.9 0.23 0.05 3.8 4.1 B-2-3, F, Mc, Md
9.9–47.5
12 Lvrq10 5–8 53.2 0.21 0.06 2.4 3.5 B2-3, Md
43.5–?
13 Tesq1 3–21 10.0 0.26 0.12 4.0 7.2 B3, LeR, Z
?–14.6
14 Epf%q1 50–34 20.3 0.30 0.33 5.3 6.0 B3
?–34.5
15 Scfq2 13–1 25.2 0.26 0.35 5.0 4.4 B2-3, G, H, P, PH, W, Wd, Y
8.8–39.6
15 Epf%q4 13–1 33.4 0.25 0.66 3.4 3.4 B3, G, H, K, P, PH, W
21.1–46.3
15 Epf%q3 1–15 51.1 0.26 0.07 3.3 3.6 B3, K, PH
46.3–?
16 Splq8 55–57 3.4 0.03 7.5 2.0 3.9
?–10.2
17 Splq9 124–10 21.9 0.19 0.08 2.4 3.4 B2
?–32.4
17 Scfq4 124–10 21.9 0.20 0.08 3.4 4.1 B3, M2, Md, P, PH, T2-4
?–34.0
17 Epfq3 124–10 21.9 0.21 0.03 3.0 3.8 B3, M2, Md, P, PH, T2-4
?–33.2
aHrtq, Lvrq, Kidq, Splq, Tesq, Scfq, Egfq, Pwatq are symbols attributed to QTL detected for weights of Heart, Liver, Kidney, Spleen,
Testis, Subcutaneous fat pad, Epididymal fat pad, and percentage water in carcass. Symbols with % represent traits adjusted for 10-week
body weight. Numeric indices of QTL reflect a descending rank of their maximum LOD scores within trait.
bMIT markers (e.g., within MMU 1, 180 represents D1Mit180).
cApproximate positions (Mouse Genome Database) of maximum likelihood peaks (top) and respective one LOD confidence intervals
(bottom). A ‘?’ indicates that a confidence interval extends to the beginning or end of a chromosome.
dAdditive effect (Falconer and Mackay 1996) in phenotypic S.D. units (transformed scale). Negative values indicate increasing effect of the
L6 allele.
eDegree of relative dominance: 0 indicates additivity; 1, full dominance of the M16i allele; and 1, full dominance of the L6 allele.
fPercentage of phenotypic variance accounted for by QTL.
gStudies detecting QTL for similar traits in the same genomic region, listed in order of location on each chromosome (from proximal to
distal). B, B2, and B3 are, respectively, Brockmann et al. (1998a, 1998b, 2000); F, Fisler and Warden (1997); G, Gu et al. (1999); H, Horvat
et al. (2000); I, Iakoubova et al. (1995); K, Keightley et al. (1998); L, Leamy et al. (2002); Lb, Lembertas et al. (1997); LeR, Le Roy et al. (2001);
M and M2, Mehrabian et al. (1998, 2000); Mc, Machleder et al. (1997); Md, Moody et al. (1999); P, Pomp (1997); PH, Purcell-Huynh et al.
(1995); Rb, Roberts et al. (2000); S, Suto et al. (1999); Sc, Schadt et al. (2003); Sp, Spearow et al. (1999); T and T2, Taylor and Phillips (1996,
1997); T3 and T4, Taylor et al. (1999, 2001); W and W2, West et al. (1994, 1995); Wd, Warden et al. (1995); Y, York et al. (1996); and Z, Zidek
et al. (1998).
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Table 4. Summary of estimates of QTL effects and gene action across traits
Traita #QTLb #Chrb Avg. ac Max. a Min. a Avg. dd Max. d Min. d
HRT 3 2 0.29 0.34 0.26 0.02 0.36 0.18
LIV 10 8 0.30 0.54 0.21 0.05 0.48 1.3
KID 7 5 0.27 0.43 0.18 0.15 0.57 0.12
SPL 9 7 0.25 0.42 0.03 1.0 0.13 7.5
TES 3 3 0.19 0.26 0.19 0.86 2.1 0.36
SCF 4 4 0.24 0.26 0.26 0.18 0.35 0.35
EPF 5 4 0.24 0.31 0.19 0.08 0.43 0.47
PWAT 1 1 0.20 – – 0.0 – –
HRT% 1 1 0.23 – – 0.9 – –
KID% 2 2 0.17 0.09 0.25 1.3 1.2 3.7
SCF% 1 1 0.19 – – 2.3 – –
EPF% 4 3 0.28 0.25 0.30 0.22 0.66 0.33
aHRT, LIV, KID, SPL, TES, SCF, EPF, PWAT are weights of Heart, Liver, Kidney, Spleen, Testis, Subcutaneous fat pad, Epididymal fat pad,
and percentage water in carcass. Symbols with % represent traits adjusted for 10-week body weight. QTL for adjusted traits detected in
same genomic regions as QTL detected from unadjusted models were not included.
bNumber of QTL and number of chromosomes in which QTL were detected for the trait.
cAverage of absolute values of a.
dAverage of degree of directional dominance (not average of absolute values of d).
Table 5. Summary of magnitudes of QTL effects across traits
Traita Avg % Var Max % Var Min % Var Total % Varb First 5 % Varc Last 5 % Vard Avg CIe
HRT 8.0 12.8 5.0 19.0 – – 23.8
(26.0) (32.3–8.1)
LIV 7.9 23.3 2.4 – 34.5 17.4 22.7
(86.3) (34.3–5.2)
KID 6.5 17.2 1.3 – 24.1 12.4 24.5
(44.3) (43.3–7.6)
SPL 6.3 16.0 2.0 – 26.5 13.9 21.4
(65.7) (27.1–9.0)
TES 4.9 7.3 3.3 10.7 – – 28.4
(13.7) (–)
SCF 4.5 5.9 3.4 19.5 – – 25.2
(31.6) (37.6–7.2)
EPF 3.8 6.7 2.5 15.8 – – 7.4
(43.7) (7.8–6.9)
PWAT 3.1 – – 3.1 – – 35.0
(4.4) (–)
HRT%e 4.3 – – 4.3 – – 37.0
(–) (–)
KID%e 6.6 7.0 6.1 12.5 – – 32.9
(–) (–)
SCF%e 12.0 – – 12.0 – – 34.8
(–) (–)
EPF%e 3.3 5.3 1.0 11.1 – – 22.9
(–) (25.2–20.5)
aHRT, LIV, KID, SPL, TES, SCF, EPF, PWAT are weights of Heart, Liver, Kidney, Spleen, Testis, Subcutaneous fat pad, Epididymal fat pad,
and percentage water in carcass. Symbols with % represent traits adjusted for 10-week body weight. QTL for adjusted traits detected in
same genomic regions as QTL detected from unadjusted models were not included.
bTotal percentage of phenotypic variance accounted for by all QTL detected for a trait. For some traits, the large number of QTL detected
precluded estimation of this statistic. In parentheses is the percentage of the F2 range accounted for when additive effects (2a) of all QTL
detected for a trait are summed (transformed scale).
cTotal percentage of the phenotypic variance accounted for by largest five QTL.
dTotal percentage of the phenotypic variance accounted for by smallest five (or remaining) QTL.
eAverage length (range) of the one LOD confidence intervals defined for the trait QTLs (situations where one of the CI boundaries could
not be defined are excluded from this average). In parentheses are the corresponding maximum and minimum lengths of such CIs.
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respective roles in reproduction and disease resist-
ance, both exhibited relatively strong directional
dominance. The limited explorations of epistasis
that were conducted (see Rocha et al. 2004a for
methods) revealed little evidence for interactions
among QTL affecting individual organ and fat pad
weights.
Nearly 25% (12) of detected QTL are located on
Chromosome (Chr) 2, reflecting the large effects
detected for aggregate body weight (Rocha et al.
2004a) and1 reproduction (Rocha et al. 2004c) traits.
Likelihood plots for Chr 2 QTL for fat traits are
provided in Fig. 1. QTL peaks for fat traits appear to
match the peak representing the more distal QTL for
WT10wk (Rocha et al. 2004a). This potentially plei-
otropic locus likely reflects patterns of fat deposition
with increasing maturity and the strong correlation
between weight and fat in mice.
Fitting of alternative statistical models, with or
without covariate adjustments, provides in some
cases indirect evidence for existence of multiple
linked QTL for the same trait. One such example for
the case of potentially two QTL for SPL detected on
MMU1 is illustrated in Fig. 2. This plot could rep-
resent a statistical artifact from the fitting of simple
QTL models. However, the fact that adjustment for
body weight differentially impacts the two putative
and linked QTL lends some support to the possibil-
ity that these are in fact two distinct yet linked QTL,
one impacting SPL independent of body weight.
Formal tests comparing two QTL models relative to
single QTL models will be employed in the future
across this entire data set.
Figures 3 and 4 schematically summarize the
genomic bases of components of 10-week body
weight. Only rarely were QTL detected for organ and
fat traits that did not overlap with the confidence
intervals of QTL that had previously been detected
for aggregate growth traits (Rocha et al. 2004a). The
unique relevance of Chr 2 in the context of this cross
is further demonstrated.
Discussion
Obesity exacts an immense economic and social toll,
accounting for 7% of US health expenditures and
leading to potential bias and discrimination in em-
ployment, education, and health care (NHLBI 1998).
It is an exceptionally complex disorder, with rela-
tively equal contributions of multifactorial genetic
susceptibility and interacting environmental factors
(Pomp 1997). Predisposition to obesity results from
combinations of relatively small effects of genetic
variations within a large number of polygenes (QTL;
Brockmann and Bevova 2002) of yet unidentified
function.
The present results, in combination with a con-
current analysis of growth and body weight (Rocha
et al. 2004a), have added new information to the
predisposition map for mouse body weight regula-
tion, and have further partitioned body weight QTL
in terms of adipose tissue and weights of various
organs. The vast majority of growth QTL, impacting
different age periods, can be interpreted in terms of
fat and organ subcomponents measured. Muscle,
bone, gut, skin, and various small organs were not
measured in this experiment. Many studies (Belknap
et al. 1992; Brockmann et al. 2000; Williams 2000;
Airey et al. 2001; Williams et al. 2001; Leamy et al.
2002) have identified QTL for several of these un-
measured subcomponents which match some of the
growth QTL identified in the present study that have
Fig. 1. QTL likelihood plots for Chr 2 re-
sulting from Composite Interval Mapping
for 10-week body weight (WT10wk) and
weights of subcutaneous (SCF) and epi-
dydimal (EPF) fat depots.
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unknown underlying subcomponents. Additionally,
only a few QTL (and primarily those with small ef-
fects) detected for organ subcomponents in this
study did not overlap with confidence intervals of
QTL that were detected for the aggregate growth
traits (Rocha et al. 2004a).
Our results strongly re-emphasize the observa-
tion of Mehrabian et al. (1998) regarding commo-
nality of genomic regions impacting obesity traits
across many different genetic backgrounds. The QTL
for fatness we report on Chr 2, 7, 15, and 17 appear to
be obesity genomic hot-spots, although caution is
required when assuming that the underlying genes
in each region are identical in each genetic back-
ground.
Large effects of QTL impacting aggregate growth
of the organism, growth of most organs, and espe-
cially fatness are present on mouse Chr 2. In regard
to obesity predisposition, distal Chr 2 appears to be
one of the most relevant regions of the mouse ge-
nome. Not only is this region well populated with
multiple body weight and fatness QTL as deter-
mined from crosses employing different approaches
and genetic backgrounds (Lembertas et al. 1997;
Pomp 1997; Mehrabian et al. 1998; Schadt et al.
2003a), the QTL harbored in this region in the M16
selection line appear to have among the largest ef-
fects of any body weight regulating polygenes ever
localized. Since distal MMU2 and HSA20 (from p13
through q13) form continuous stretches of synteny
between the two species, identification of the genes
underlying obesity QTL in this region of the mouse
represents an excellent opportunity for comparative
mapping and application of murine models to stud-
ies of human health. The importance of this is am-
plified by the findings from several groups that the
homologous region of HSA20 harbors genes influ-
encing predisposition to obesity and diabetes in hu-
mans (see Chagnon et al. 2003).
Efforts to identify and characterize the M16-
based distal MMU2 weight and fat QTL are under
way (Jerez-Timaure et al. 2002; Pomp et al. 2002).
Our detailed studies in this region using M16i and an
M16i.B6-(D2Mit306–D2Mit52) congenic line (re-
ferred to as MB2) strongly indicate the presence of
multiple linked QTL with effects on weight and
fatness (Jerez-Timaure and Pomp, unpublished). Ef-
forts at positional cloning are further complicated by
the fact that this region of the mouse genome is
known to contain many genes involved in regulation
of energy balance. For these reasons, success in this
endeavor will likely require experimental approach-
es that combine functional analyses with the re-
solving power of recombination.
A new paradigm for bridging the gap between our
knowledge of the physiology and predisposition of
obesity is to combine QTL mapping with large-scale
gene expression analysis. Transcriptome mapping,
also called ‘‘genetical genomics’’ (Jansen and Nap
2001; Jansen 2003), treats levels of gene expression of
any particular gene measured across different indi-
viduals as an expression-level polymorphism that in
principle reflects the underlying genetic variation
(Dumas et al. 2000; Jansen and Nap 2001; Doerge
2002). This type of analysis was pioneered by de
Vienne et al. (1994), using proteomic evaluation
[later extended by the same group to the transcrip-
tome (Consoli et al. 2002)] in an F2 population of
Fig. 2. QTL likelihood plots for Chr 1 re-
sulting from Composite Interval Mapping
for spleen weight by fitting alternative
statistical models: with (SPL%) and
without (SPL) covariate adjustment for
body weight.
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Fig. 3. Chromosomes responsible for 10-week body weight, as assessed from the results of Rocha et al. (2004a), and
corresponding assignments in terms of organ and fat subcomponents based on overlapping confidence intervals. In some
cases, unequal relative areas represent different numbers of QTL detected for the different traits. On MMU1, two QTL for
spleen were found, while other organs are represented by a single QTL. On MMU2 all organs are represented by two QTL
except for SCF (subcutaneous fat), for which only one QTL was localized.
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maize. Transcriptome mapping is a powerful mech-
anism to dissect complex traits and make more ef-
ficient the selection of candidate genes underlying
predisposition loci, with recent successful imple-
mentation in yeast (Brem et al. 2002), Drosophila
(Wayne and McIntyre 2002), and mice (Schadt et al.
2003a, 2003b).
By identifying expression QTL that coincided
with a QTL peak for, and had correlations with,
subcutaneous fat mass, Schadt et al. (2003a) pro-
posed the NM_025575 and NM_15731 genes as pri-
mary candidates for the distal MMU2 QTL for
dietary-induced obesity described by Lembertas et al.
(1977). These candidate genes also possibly overlap
with the obesity QTL we identified in this region.
Important distinctions exist between the results
from Schadt et al. (2003a) and those from the present
experiment. Distinctly different genetic models
were used. Obesity in the M16 line does not require
high levels of dietary fat. Indeed, no interactions
between dietary fat consumption and effects of
MMU2 QTL on body fat levels were found when
comparing the M16i selection line and MB2. This
lack of interaction is noteworthy given that the
donor line for MB2 is C57, which is one of the strains
used in the Schadt et al. (2003a) study, and which
is among the strains most responsive to dietary-
induced obesity (West et al. 1992). Nevertheless,
localization of candidate genes identified by Schadt
et al. (2003a) at 165 MB on distal MMU2 aligns
Fig. 4. A) relative numbers of QTL associated with each of the subcomponent organ and fat traits (under the broad general
assumption that body composition evaluated at 10 weeks harbors relevant information regarding body composition
changes in each growth period); and B), relative contributions of each chromosome to the total growth process in terms of
QTL numbers for all organs.
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with the QTL peak for the Epfq2 locus, representing
the more distal of the two obesity QTL found in our
study and the one with significantly smaller effects.
However, preliminary data from our subsequent
fine-mapping efforts with MB2 indicate that the best
supported position for Epfq2 may be at 159 MB
(Jerez-Timaure and Pomp, unpublished).
QTL for specific organ weights that support
findings from independent studies are those for testis
weight on the proximal region of MMU13, spleen
weight on MMU1 (more proximal of the two de-
tected), and kidney weight on MMU11. In this re-
spect, MMU11 is second in importance to MMU2 in
regard to effects on components of body weight in
the context of this cross. Surprisingly, the only QTL
detected for percentage water in the carcass did not
match any of the QTL detected for fat traits, which
may reflect the different nature of the two pheno-
types. PWAT exhibits much less variability than
SCF or EPF and is impacted not only by fat content
but also by protein and mineral content. Neverthe-
less, results from other studies provide some support
for the existence of a QTL for PWAT on MMU1,
through both an impact on fat content (Purcell-Hu-
ynh et al. 1995; Machleder et al. 1997; Moody et al.
1999; Suto et al. 1999; Taylor et al. 2001) and/or
mineral content (Leamy et al. 2002).
Liver and testis are those organs whose weights
have the largest and the smallest numbers of QTL,
respectively. Liver weight is the most aligned with
growth of the overall organism, while testis weight
is the least aligned with overall growth. Strong QTL
congruencies exist among liver, heart, kidney, and
spleen weights, in agreement with phenotypic cor-
relations and paralleling results reported by other
studies that have undertaken detailed organ sub-
component analyses (Kramer et al. 1998; Brockmann
et al. 2000; Leamy et al. 2002). The latter two stud-
ies, which included comprehensive QTL analyses for
organ and fat subcomponents, corroborate many of
our present findings. Such agreement is not surpris-
ing, especially in regard to Leamy et al. (2002) and
Pomp (1997), who analyzed data from a cross that
also utilized the M16i selection line.
An interesting finding from this study concerns
how different covariate adjustments may in some
cases provide strong evidence supporting the exist-
ence of multiple linked QTL. Average additive QTL
effects and average variance QTL effects for body
composition traits are relatively larger than those
reported for the aggregate growth traits (Rocha et al.
2004a). This may represent differences in genetic
architecture of the traits, but more likely reflects the
smaller sample size in the body composition analy-
sis, which will tend to lead to estimates having an
upward bias (Beavis 1998; Melchinger et al. 1998;
Utz et al. 2000).
Directional dominance is not expected to play
much of a role for the organ and fat traits studied at
10 weeks of age, as heterosis observed for corre-
sponding traits in livestock species is usually mini-
mal. Estimates of dominance effects match that
expectation, with small average values reflecting
predominantly additive gene action. Testis and
spleen weights provide exceptions. This would per-
haps be expected for testis weight, given the classical
relevance of dominance and heterosis for reproduc-
tive (fitness) traits. Regarding spleen weight, the
high average dominance values may be related to the
involvement of this organ in disease-resistance
mechanisms, which are traits for which dominance
and heterosis are generally important.
Comparisons of the total amount of variance
accounted for by all QTL, when fitted together, and
the sum of the individual fractions of variance ex-
plained by individual QTL provide limited evidence
about the relevance of epistatic interactions on
phenotypic expression of these traits (i.e., with no
epistasis, the two values should coincide). On the
basis of this approach, organ and fat subcomponents
of body weight appear to be traits for which epistasis
is especially not important. However, validation of
this finding requires more thorough statistical ap-
proaches (i.e., fitting of multiple QTL models).
While molecular biology has yielded advance-
ments in understanding weight regulation at the
metabolic and physiological levels [see reviews by
Bray and Tartaglia (2000) and Barsh and Schwartz
(2002)], the genetic architecture of obesity remains
essentially undefined. And while QTL maps for
obesity-related traits are well represented in both
mice (Brockmann and Bevova 2002) and humans
(Chagnon et al 2003), only a few isolated cases of
obesity in humans can be attributed to mutations
within genes exerting effects in well-characterized,
energy-balance pathways (Chagnon et al. 2003). This
gap between our knowledge of physiological mech-
anisms underlying obesity and the nature of genetic
predisposition to obesity greatly impairs the ability
to identify relevant QTL, which in turn limits de-
velopment of gene-based tools for diagnosing, treat-
ing, and eventually preventing obesity and related
diseases. Our future objective is to use the M16
obesity model to integrate genetics and physiology
and resolve the macro level of phenotypic expression
in terms of successive subcomponent layers (e.g., de
Vienne et al. 1994; Flint and Mott 2001; Schadt et al.
2003a, 2003b) to the level of integrated and inter-
acting pathways of biochemical networks. When
this approach is anchored with a sound understand-
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ing of the corresponding genomic organization re-
sponsible for the operation of physiological systems,
resolution at the level of single genes or integrated
sets of interacting genes may become more readily
attainable.
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